Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-03-06 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings
2009-03-06 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is very short (245 characters) and announces a specific financial metric, 'Indre værdi' (Net Asset Value), for a specific date (March 6, 2009). This directly corresponds to the definition of Net Asset Value updates, which is classified as NAV.
2009-03-06 English
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (246 characters) and announces a specific financial metric, 'Indre værdi' (Net Asset Value), for a specific date (March 5, 2009). This directly corresponds to the definition of Net Asset Value updates, primarily for investment funds. The Danish term 'Indre værdi' translates directly to NAV. Therefore, the classification should be NAV.
2009-03-05 English
Regulatory Filings 2009
Regulatory Filings
2009-03-05 Danish
Audit Report / Information 2008
Audit Report / Information Classification · 98% confidence The document is titled "Årsrapport" (Annual Report) in Danish. It contains a detailed table of contents listing sections like "Ledelsens beretning" (Management's report), "Finansielle hoved- og nøgletal" (Key financial figures and ratios), "Resultatopgørelse" (Income Statement), "Balance" (Balance Sheet), and "Noter til årsregnskabet" (Notes to the annual accounts). Furthermore, it presents comparative financial data spanning multiple years (2004-2008) and discusses the company's performance, strategy, and outlook for the year. This structure and content are characteristic of a comprehensive annual financial report, which corresponds to the definition of a 10-K (Annual Report), even though the document is in Danish and not explicitly labeled '10-K'. Given the comprehensive nature and the inclusion of audited financial statements (implied by the structure and the mention of the independent auditor's report), it is classified as an Annual Report. FY 2008
2009-03-04 English
Annual Report 2009
Annual Report
2009-03-04 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.